Vastagbélrák: vizsgálatok itt: Ausztria

21 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  Where

  Salzburg, Vienna, Wiener Neustadt

  Életkor

  18 év and over

  People

  1020 worldwide

  Run by

  EMD Serono Research & Development Institute, Inc.

  See details and how to joinNCT07549412 · EU 2025-524648-37-00
• No phaseTaking people
  Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal Cancer

  Where

  Bregenz, Feldkirch, Hohenems, Rankweil

  Életkor

  18 év and over

  People

  200

  Run by

  Vorarlberg Institute for Vascular Investigation and Treatment

  See details and how to joinNCT07913802
• 1/2. fázisTaking people
  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  Where

  Linz

  Életkor

  18 év and over

  People

  160 worldwide

  Run by

  Eikon Therapeutics

  See details and how to joinNCT07262619 · EU 2026-525248-13-00
• 3. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  Where

  Graz, Linz, Salzburg, Vienna

  Életkor

  18 év and over

  People

  700 worldwide

  Run by

  Incyte Corporation

  See details and how to joinNCT07284849 · EU 2025-523735-19-00
• No phaseTaking people
  ABCSG R07 Rectal Cancer Registry

  Where

  Graz, Innsbruck, Linz, Salzburg, Wiener Neustadt

  Életkor

  18 év and over

  People

  600

  Run by

  Austrian Breast & Colorectal Cancer Study Group

  See details and how to joinNCT07780305
• 2. fázisTaking people
  A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

  Where

  Graz, Salzburg, Vienna

  Életkor

  18 év and over

  People

  390 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06820463 · EU 2024-512981-33-00
• 3. fázisNot yet taking people in Ausztria
  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  Where

  Linz, Salzburg

  Életkor

  18 év and over

  People

  450 worldwide

  Run by

  Genmab A/S

  See details and how to join2026-525883-17-00 · EU 2026-525883-17-00
• 2/3. fázisTaking people
  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  Where

  Feldkirch, Linz, Salzburg, St. Poelten, Vienna

  Életkor

  18 év and over

  People

  990 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07221357 · EU 2025-523224-45-00
• 1. fázisTaking people
  Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  Where

  Graz, Vienna

  Életkor

  18 év and over

  People

  1394 worldwide

  Run by

  Exelixis

  See details and how to joinNCT05176483 · EU 2023-510061-10-00
• 3. fázisTaking people
  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  Where

  Graz, Linz, Rankweil, Vienna, Wiener Neustadt

  Életkor

  18 év and over

  People

  450 worldwide

  Run by

  Amgen

  See details and how to joinNCT06252649
• 3. fázisTaking people
  Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

  Where

  Feldkirch, Graz, Linz, Vienna, Wiener Neustadt

  Életkor

  18 év to 64 év

  People

  241 worldwide

  Run by

  Amgen Inc.

  See details and how to join2022-502352-31-00 · EU 2022-502352-31-00
• 3. fázisTaking people
  A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  Where

  Salzburg, Vienna, Wels, Wiener Neustadt

  Életkor

  18 év and over

  People

  400 worldwide

  Run by

  Seagen, a wholly owned subsidiary of Pfizer

  See details and how to joinNCT05253651 · EU 2024-514180-25-00
• 2. fázisTaking people
  – IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases

  Where

  Linz, Salzburg, Wiener Neustadt

  Életkor

  18 év and over

  People

  140 worldwide

  Run by

  Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

  See details and how to join2024-519929-38-00 · EU 2024-519929-38-00
• No phaseTaking people
  GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer

  Where

  Graz

  Életkor

  18 év and over

  People

  590 worldwide

  Run by

  Claus Lindbjerg Andersen

  See details and how to joinNCT06111105
• No phaseTaking people
  Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line

  Where

  Linz

  People

  102

  Run by

  Kepler University Hospital

  See details and how to joinNCT07506005
• 2. fázisTaking people
  - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

  Where

  Linz, Salzburg, Wiener Neustadt

  Életkor

  18 év and over

  People

  140 worldwide

  Run by

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

  See details and how to joinNCT06856837
• No phaseTaking people
  AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond

  Where

  Linz, Rankweil, Salzburg, Steyr, Wels, Zams

  Életkor

  18 év and over

  People

  500

  Run by

  Arbeitsgemeinschaft medikamentoese Tumortherapie

  See details and how to joinNCT06678919
• No phaseTaking people
  The DRAGON 2 Trial

  Where

  Vienna

  Életkor

  18 év and over

  People

  348 worldwide

  Run by

  Maastricht University

  See details and how to joinNCT05428735
• No phaseTaking people
  Establishment of a Tumor Bank for Blood Samples

  Where

  Innsbruck

  Életkor

  18 év and over

  People

  10 000 worldwide

  Run by

  Medical University of Vienna

  See details and how to joinNCT01763125
• No phaseTaking people
  Establishment of a Tumor Bank for Tissue Samples

  Where

  Vienna

  Életkor

  18 év and over

  People

  10 000 worldwide

  Run by

  Medical University of Vienna

  See details and how to joinNCT01789229
• No phaseTaking people
  BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment

  Where

  Braunau am Inn, Feldkirch, Linz, Vienna

  Életkor

  18 év and over

  People

  500 worldwide

  Run by

  Pierre Fabre Pharma GmbH

  See details and how to joinNCT04673955